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ABSTRACT 
Advances in measurement technology and wireless signal transfer have enabled the 
design of new, smaller and portable—even plaster-like—electrocardiographic (ECG) 
measurement devices that enable patient monitoring at home or in emergency 
situations. The development of new, miniaturized biomedical sensors has opened up 
possibilities for their application, but also set new demands on signal analysis and 
interpretation. In particular, the new small wireless systems often utilize bipolar 
electrodes that have a shorter interelectrode distance (IED) and different electrode 
locations from those of the standard 12-lead system. This affects the quality and the 
information content of the signal. The general objective of this thesis was to evaluate 
the performance of short IED precordial bipolar ECG leads and to determine their 
optimal location. 
 
This thesis adopted three methods to assess the properties of new bipolar precordial 
ECG leads: modeling, body surface potential map (BSPM) data, and exercise ECG 
data. First, two realistic, three-dimensional (3D) thorax models and lead field analysis 
were used to evaluate whether modeling of the measuring sensitivity of ECG leads 
could be used as a tool for designing new ECG leads. Second, BSPM data was used to 
study whether short-distance bipolar leads (IED approximately 6 cm) provide an ECG 
signal that is adequate for clinical utilization. Third, BSPM data was used to define 
where a bipolar ECG lead should be located in order to maximize the ECG signal 
strength within healthy subjects. Finally, the value of bipolar leads for diagnosing two 
major cardiac conditions—left ventricular hypertrophy (LVH) and coronary artery 
disease (CAD)—was assessed. 
 
It was found that the modeled measuring sensitivity corresponds to the changes in 
actual ECG signal strength, so modeling can be useful, especially in cases where in 
vivo measurements are impossible such as in designing implantable applications. 
Based on ECG data from 236 healthy subjects, all studied bipolar ECG leads with a 
short IED (approximately 6 cm) provided a detectable signal when compared to a low 
noise level of 15 µV and considering the P-wave as the smallest parameter. The 
optimal location of the bipolar lead was diagonally near the chest electrodes of the 
standard precordial leads V2, V3, and V4 (to maximize QRS amplitude), or above the 
chest electrodes of leads V1 and V2 (to maximize P-wave amplitude). In the selected 
clinical applications, LVH and CAD, the performance of bipolar leads was 
surprisingly good. In differentiating LVH (n=305) and healthy subjects (n=236), the 
performance of a correctly positioned small bipolar lead was similar to that of the 
traditional Sokolow-Lyon method. When differentiating CAD (n=255) patients from 
non-CAD (n=126) or low-likelihood of CAD (n=198) subjects, the overall 
performance of bipolar lead CM5 corresponded to that of standard lead V5. 
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These results indicate that short IED bipolar leads provide a signal that is adequate for 
clinical use. Furthermore, the performance of these leads was shown to be similar or 
even superior to that of the commonly used standard leads. It can be concluded that 
when correctly positioned, short IED bipolar leads are useful and can give additional 
value for clinical diagnostics. These results provide promising information on the 
applicability and potential of short IED bipolar ECG leads, and demonstrate that they 
are worth developing further. 
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1. INTRODUCTION 
The aim of this thesis is to evaluate the performance and find the optimal location for 
new bipolar ECG leads with a short interelectrode distance (IED). Cardiac activity is 
traditionally recorded with the standard 12-lead ECG system; however, the trend in 
healthcare is towards mobile, minimally obtrusive, individualized health services. 
Thus, there is an increasing interest in developing alternative electrode locations for 
physiological monitoring. As electronics become miniaturized and implantable devices 
are developed, new possibilities for long-term measurement are opened up in areas 
such as emergency care and remote monitoring. A variety of commercialized, mobile 
ECG systems have emerged over the last decade, including the chest-worn heart-rate 
belts by Polar and Suunto for the wellness and lifestyle market (Polar, Suunto). Small, 
handheld ECG applications include those developed by BlackBerry/Vodafone, the 
Apple iPhone ECG System developed by Alivecor and Oregon Scientific, and Omron 
HeartScan (BlackBerry, AliveCor, Omron). In addition, several devices for remote, 
wearable, or continuous ECG monitoring have been developed for research purposes. 
 
Mobile and continuous ECG recording could be especially useful for individuals with 
a risk of heart problems, as it enables cardiac activity to be monitored unobtrusively in 
the home environment. In addition, remote monitoring enables health providers to 
access data in real time and possibly detect paroxysmal events. Urbanization, ageing, 
and lifestyle changes make chronic and non-communicable diseases—including 
cardiovascular disease—increasingly important causes of morbidity and mortality 
(WHO 2008). Finnish statistics show that as the population ages, ischemic heart 
diseases are becoming an increasingly widespread cause of death. In 2009, ischemic 
heart disease was the direct cause of death in 22% of all cases in the Finnish 
population (Statistics Finland). The main cause of ischemia in the heart muscle is 
coronary artery disease (CAD). In addition, left ventricular hypertrophy (LVH) is a 
potent, independent predictor of cardiovascular events, particularly in hypertension, in 
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which it dramatically increases the risk of stroke, coronary heart disease, and heart 
failure. The importance of diagnosing LVH has increased in recent years with the 
recognition that hypertrophy can be reversed and the adverse clinical outcomes 
delayed (Mathew 2001; Okin 2003). Hence, an early diagnosis of cardiac diseases 
such as LVH or CAD is important when it comes to treating the condition and 
delaying or preventing adverse clinical outcomes.  
 
Remote home monitoring in everyday life could give additional tools for the early 
detection and prevention of cardiac diseases. In this vein, research and development 
related to wearable and implantable ECG recorders has been emerging over the past 
decade. Wearable devices can enhance the user’s comfort and enable monitoring of the 
patient at home instead of in the hospital. Thus, unnecessary hospitalizations can be 
avoided, which again will reduce healthcare costs. Another benefit is that by applying 
new measurement devices, we can possibly enhance diagnostic accuracy and ensure 
that those who need urgent care get it as quickly as possible. In addition, sophisticated 
monitoring and communication systems can enable interaction between patient and 
healthcare professional at any time it is needed. All of these issues are of interest for 
future healthcare. 
 
Wearable ECG monitors often require a shorter IED and different electrode locations 
than those of the traditional 12-lead system. Both applying new measurement 
configurations and reducing the IED affect the morphology and amplitudes of the 
measured signals, thus having an impact on diagnostics. For this reason, it is crucial to 
evaluate the performance of short-distance bipolar leads as candidates for wearable 
electrode leads, and to study how the electrode location and orientation influence the 
recorded signal. Modeling tools offer one means of studying the behavior of 
physiological signals. 
 
Modeling has been used in a variety of applications in electrocardiology, ranging from 
the earliest homogeneous thorax ECG models used by Frank (Frank 1954; Frank 1956) 
to the development of implantable defibrillators (Gale 1994). The main benefit of 
modeling is that it enables phenomena to be investigated when it would be too tedious 
or impossible to study them using in vivo trials. Modeling also provides the possibility 
to study the sensitivity distributions of bioelectric measurements. This could be useful 
in designing measurement devices for conditions where the changes appear in a certain 
area of the cardiac muscle, such as in LVH or myocardial infarction (MI). 
 
Another way of testing new electrode locations is by utilizing body surface potential 
maps (BSPM), which provide multielectrode ECG signals. BSPMs contain diagnostic 
information not present in conventional lead systems, and offer the possibility to 
analyze signals in several locations on the body surface. BSPMs have been used, e.g., 
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to identify the best ECG leads for diagnosing acute myocardial ischemia or LVH 
(Kornreich 1988; Kornreich 1991; Kornreich 1998; Oikarinen 2004; Kornreich 2008), 
or determining the optimal locations for a small implantable ischemia monitor (Burke 
2003; Song 2004; Arzbaecher 2006). When designing new, small, wearable or wireless 
ECG measurement systems, BSPM databases provide a good way to test new 
electrode locations with different subjects. 
 
All in all, mobile and wearable ECG devices have been available for a while, but their 
additional value is marginal if we do not know where the recording electrodes should 
be placed to obtain a strong, reliable ECG signal. There is a lack of extensive studies 
on signal quality and robustness, as well as the optimal lead location, for new, small 
ECG measurement systems. The aim of this thesis is to investigate the performance of 
and determine the optimal location for closely spaced bipolar ECG leads that can be 
used in wireless, wearable, or even implantable ECG recorders. The study population 
included both healthy subjects and subjects with LVH or CAD. The results of this 
thesis provide new information on the applicability of novel bipolar ECG leads and the 
possibilities that they offer for future healthcare. 
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2. OBJECTIVES OF THE STUDY 
 
The general objective of this thesis was to evaluate the performance of new, short IED 
precordial bipolar ECG leads and to determine their optimal location. First, these new 
leads were modeled; they were then studied in relation to an ECG BSPM database of 
normal subjects. Finally, the value of the new bipolar leads in the detection of two 
main cardiovascular diseases, LVH and CAD, was assessed.  
 
The specific aims were as follows: 
 
1. To evaluate whether modeling the sensitivity of ECG leads with realistic thorax 
models could be used as a tool for designing new ECG leads [I]; 
 
2. To determine whether short-distance bipolar ECG leads can provide an ECG 
signal that is adequate for clinical utilization [II]; 
  
3. To study where the new bipolar lead should be located in order to obtain the 
optimal ECG signal strength within healthy subjects [II]; 
 
4. To assess the value of new bipolar leads in diagnosing LVH and CAD [III and 
IV]. 
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3. REVIEW OF THE LITERATURE 
This chapter comprises a review of the literature with an emphasis on wireless ECG 
applications. In addition, the methods adopted in this thesis—modeling, BSPM, and 
exercise testing in electrocardiology—are introduced. Finally, the two cardiovascular 
diseases addressed in this thesis, specifically CAD and LVH, are briefly described. 
3.1 Electrocardiography and wireless applications 
Electrocardiography (ECG) is a tool that measures the electrical activity generated by 
the heart. During each heartbeat in a healthy heart, a wave of depolarization is 
triggered by the cells in the sinoatrial node; this spreads out through the atrium, passes 
through the atrioventricular node, and then spreads all over the ventricles. This is 
followed by repolarization. The recorded tracing is called an electrocardiogram (ECG), 
and this typically comprises of the following waves: the P-wave, representing atrial 
depolarization; the QRS complex, representing ventricular depolarization; and the T-
wave, representing ventricular repolarization (Figure 1). Because the body acts as a 
volume conductor, this electrical activity generated by the heart can be measured with 
electrodes placed on the body. 
 
 
Figure 1. Normal electrocardiogram. 
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The ECG is traditionally recorded with the standard 12-lead system, which comprises 
six chest and six limb leads. The word lead refers to the voltage difference between the 
measuring electrode and the reference. The chest leads V1-V6 are unipolar, with 
Wilson’s central terminal (WCT), which is the average of the limb electrode 
potentials, as a reference. Three of the limb leads are bipolar (I-III), measuring the 
potential difference between two electrodes, and another three are augmented unipolar 
leads (aVR, aVL, aVF), where the reference for the measurement electrode is the 
average of two other limb leads. The number of leads and the electrode placement has 
remained the same for over a half century, although the technology for measuring 
physiological signals has developed rapidly. The standard 12-lead system ECG is an 
invaluable tool, but new wearable and implantable devices offer new means of 
recording ECG signals for different applications. The American College of Cardiology 
(ACC) and the American Heart Association (AHA), in collaboration with the North 
American Society for Pacing and Electrophysiology, have developed guidelines for the 
use of ambulatory ECG (Crawford 1999). Several wireless, mobile, and wearable 
systems have been developed over the last decade; these are discussed below. 
 
Wireless ECG 
The origin of telemetric cardiac monitoring goes back to the early 1960s, when the 
clinical use of Holter monitors began. The Holter monitor is named after physicist 
Norman J. Holter, and the term refers to a portable device used to monitor bioelectrical 
signals. It is widely employed in electrocardiology for long-term, continuous 
monitoring of cardiac activity, and is usually worn for 24–48 hours during normal 
activity. Holter monitors have three to seven wires, depending on the model, and they 
can be used for recording unipolar or bipolar signals. Many new wearable and portable 
measurement systems use bipolar leads, meaning that the signal is detected between 
two recording electrodes. One well-known example of a wearable device is the heart 
rate (HR) monitoring belt, which has become widespread and a daily routine for many 
athletes. 
 
The miniaturization in electronics and advances in signal transfer have enabled the 
development of small, plaster-like devices that include the measurement electronics 
and wireless transfer for measuring ECG. The IED used in the following devices 
corresponds to that studied in this thesis. Fensli et al. (Fensli 2004) introduced a small 
(70 x 35 x 18 mm) ECG sensor with an IED of 3 cm. The device utilizes wireless radio 
frequency (RF) transmission (Nordic VLSI; (NordicSemiconductor)) to a personal 
digital assistant (PDA), and provides 5 hours of operation. Another plaster-like device 
has been created by Munshi et al. (Munshi 2008), whose device measures 55 x 23 mm 
(IED = 5 cm) and utilizes wireless ZigBee (ZigBee) transmission. Russel et al. 
introduced an electrode assembly of three recording electrodes (IED = 2.48 cm) 
measuring less than 10 cm in its largest dimension (Russell 2007). This early prototype 
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of the monitor by Philips Medical Systems was capable of collecting 15 hours of ECG 
on three channels.  
 
Another device of three electrodes was recently introduced by Trobec et al. (Trobec 
2010). Their device used three wireless body electrodes (WBE) and bipolar 
configurations (IED = 5 cm) to synthesize the standard 12-lead ECG. The researchers 
reported that the 12 synthesized signals were similar to those of the simultaneously 
measured 12-lead ECG. Their device used the SimpliciTi (SimpliciTi) transfer 
protocol, and an operation time of 100 hours was reported. Another application using 
three wireless ECG electrodes was introduced by Chiu et al. They showed that a three-
lead ECG from closely (10 cm) spaced wireless electrodes, located in the area of 
standard 12-lead system chest electrodes, was similar to the signal recorded from 
standard leads I, II, and III (Chiu 2011). The researchers chose the electrode location 
based on our previous findings in publication [I]. Among the commercialized wireless 
electrode systems, there is also an example benefiting from plaster-like ECG: the 
CardioPatch by Novosense (Novosense). This is a fully integrated unit of 4 cm in 
diameter, containing electrodes, an ECG amplifier, and a radio transmitter. 
CardioPatch transmits the ECG signal over 24 hours to the CardioBase receiver. 
 
Signal transfer and wireless sensor networks 
The developed wireless ECG recorders utilize a variety of different protocols for 
signal transfer. In general, the device should be able to work in a license-free 
industrial-scientific-medical (ISM) band, without interfering with other devices in the 
same frequency range. In addition, the data transmission rate is an important concern. 
Considering these factors, selected transmission protocols have been utilized in 
wireless ECG development, including Bluetooth, ZigBee, sub 2.4 GHz and 2.4 GHz 
transceivers, and Wibree. Bluetooth is one of the most traditional choices, as its main 
advantages are small size, low prize, multi-user capability, and simplified setup. 
However, ZigBee has certain advantages over Bluetooth, such as lower price and 
favorable power consumption for a wider coverage area. The ZigBee protocol has 
been utilized in many body sensor networks (BSNs), including Moteiv. Moteiv was 
founded at the University of California, Berkeley, with a focus on robustness and 
application building for wireless sensor networks.  
 
Some projects have preferred a sub 2.4 GHz band for RF transmission, including 
Mica2 and Mica2Dot, both developed at University of California, Berkeley. This 
transmission protocol has been utilized, e.g., by Fulford-Jones et al. (Fulford-Jones 
2004) in developing ECG on Mica2. This group has been working with the CodeBlue 
initiative at Harvard University (Malan 2004), which has also developed VitalEKG, a 
collection of software components that allow for the capture and wireless transmission 
of heart activity traces. In general, Code Blue is a wireless infrastructure intended for 
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deployment in emergency medical care, integrating low-power, wireless vital sign 
sensors, PDAs, and PC-class systems. Similarly, researchers at the MIT Media Lab 
have developed MIThril, a wearable computing platform compatible with both custom 
and off-the-shelf sensors (DeVaul 2003). MIThril includes ECG, skin temperature, and 
galvanic skin response (GSR) sensors. Other medical applications based on wireless 
sensor networks include the scalable medical alert response system (SMART), 
MobiHealth, and CardioNet (SMART, MobiHealth, CardioNet).  Gyselinckx et al. 
have published an overview of the potential and challenges of using body area 
networks for cardiac monitoring (Gyselinckx 2007). 
 
Mobile and handheld ECG 
Recently, a range of mobile or handheld ECG applications has also been emerging. 
The BlackBerry mobile ECG application runs under the network of Vodafone, and the 
aim is to enable physicians to read the ECG reports of different patients remotely on 
their BlackBerry device (BlackBerry). Accordingly, Alivecor and Oregon Scientific 
have developed an ECG system that uses an Apple iPhone 4 and an iPhone ECG case 
containing electrodes for recording ECG (AliveCor). Another handheld device that 
records one-lead ECG is Cardio24 mobile palmtop ECG and InstantCheck mobile 
ECG by Davita (DAVITA). Generally, in these applications, the ECG signal is 
recorded by placing thumbs on the electrodes and the device records an ECG signal 
that corresponds to the standard lead I. Another option is to place the device directly 
on the chest, in which case the recorded bipolar lead is similar to the leads studied in 
this thesis. One commercial device benefiting from this measurement technique is 
Omron Heartscan Screening and Self-Monitoring of cardiac events (Omron).  
 
Wearable applications 
Wearable systems may be defined as mobile electronic devices that can be 
unobtrusively embedded in the user’s outfit as part of his or her clothing or as an 
accessory. The conventional method for recording ECG is to use electrodes (usually 
Ag-AgCl) attached to the body. However, the development of textile technology has 
produced fibers and yarns with specialized electrophysical properties. These textile 
materials enable fabric sensors to be integrated into clothing, thereby enhancing the 
comfort and usability of mobile monitoring. A recent review has been written by Chi 
et al. (Chi 2010) concerning the novel systems in the area of dry-contact and 
noncontact biopotential electrodes. LifeShirt from Vivometrics Inc. (Grossmann 2004) 
and SmartShirt from Sensatex Inc. (Sensatex) are examples of commercialized 
systems for wearable ECG monitoring. Another commercialized system is provided by 
Zephyr Technology Corp.; this measures vital signs, including ECG, breathing rate, 
skin temperature, activity, and posture (Zephyr). Several other e-textile technologies 
have been introduced that embed sensors in garments (Marculescu 2002; DeVaul 
2003; Martin 2003).  
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The Lifeguard project at Stanford University is a physiological monitoring system that 
includes physiological sensors connected to a wearable device with a built-in 
accelerometer (NASA). The HealthGear project uses a similar architecture, 
transmitting medical data to a user’s cellular phone (Flores-Mangas 2005). The 
CustoMed project at UCLA provides a plug-and-play approach to medical sensing in 
which hardware and software combinations can be customized to the needs of 
individual patients (Jafari 2005). Moreover, AMON is a EU IST funded wearable 
medical monitoring and alert system targeting high-risk cardiac/respiratory patients, 
and includes measurement of SpO2, one lead ECG, blood pressure, acceleration, and 
temperature (Anliker 2004). In our department, we have also developed textile-based 
wearable systems. We have studied the suitability of silver yarn electrodes for mobile 
ECG recording (Puurtinen 2006; Cömert 2008), and developed wearable 
electromyographic (EMG) and electro-oculographic (EOG) measurement systems for 
psychophysiological applications and computer-human interaction (Nöjd 2005; 
Puurtinen 2005
a
; Puurtinen 2005
b
; Vehkaoja 2005
a
; Vehkaoja 2005
b
).  
 
Real-time signal analysis 
The availability and low cost of personal computers and workstations has allowed for 
the development of automated signal processing algorithms. Thus, current wearable 
devices are able to provide more sophisticated signal processing tools and even real-
time signal analysis. Recently, Leijdekkers et al. reported the trial results of a cardiac 
rhythm management system using smart phones and wireless ECG sensors 
(Leijdekkers 2009). Further, Finnish CorusFit Oy and Tampere University of 
Technology have developed a system for wearable ECG monitoring during group 
training, which can be utilized for the rehabilitation of cardiac patients (CorusFit ; 
Vehkaoja 2008). Their goal is to help patients—both those already diagnosed with 
CAD and those at high risk—to achieve a permanent lifestyle change. The electrode 
montage used in their wearable ECG application is similar to lead CM5, which is also 
studied in this thesis. 
 
Implantable devices 
Sensor technology for implantable applications has also been developed to enable 
measurement of biosignals inside the human body (Riistama 2007; Väisänen 2010). 
Further, implantable cardiac event monitors have also proved effective in detecting 
cardiac arrhythmias (Benditt 2003; Burke 2003; Farwell 2004; Sarkar 2008) and acute 
ischemia (Song 2004). One publication on the CardioAlarm system concluded that a 4 
cm square subcutaneous sensor with electrodes at its corners can reliably monitor 
cardiac activity and accurately detect the occurrence of cardiac arrest (Arzbaecher 
2006). The IED (4 cm) and electrode location (near the standard electrodes V3-V4) 
used in the CardioAlarm trials is similar to that studied in this thesis. The commercial 
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implantable cardiac event monitors include those of Reveal by Medtronic (Medtronic) 
and Confirm by St. Jude Medical (StJudeMedical), which provide monitoring for up to 
3 years. They continuously monitor heart rhythms and can record an ECG at the time 
of, e.g., fainting; moreover, they may help to confirm or rule out life-threatening 
arrhythmias. 
 
Finally, it is worth mentioning that there are also emerging methods of monitoring 
ECG signals, such as capacitive sensors. The capacitive method is based on inductive 
coupling, and such devices have been reported by, e.g., Ueno et al. (Ueno 2007) and 
Lekkala et al. (Lekkala 2010). The quality of the capacitively measured signals shows 
that this method has potential for a new kind of measurement interface in wearable and 
body sensor applications where a near field reading technique can be used. 
3.2 Modeling in ECG lead development 
Human tissues have different electrical properties and the whole human body acts as a 
volume conductor. Electrical currents form one important means of cellular function 
and signal transfer in the human body, and the signals arising from bioelectrical 
sources such as the heart, brain, and skeletal muscle can be measured on the body 
surface. The fields generated by these sources can also be studied using bioelectrical 
models. To model and solve bioelectric field problems, either the forward or the 
inverse problem can be used. The forward problem is solved by starting from a given 
electrical source and conductor, and calculating the potentials at the electrodes. In 
contrast, the inverse problem means that the field and the conductor are known, but the 
source is unknown (Malmivuo 1995). The research in this thesis was conducted by 
using the inverse problem. 
 
Since investigation of the performance of new electrode systems may be tedious if 
numerous clinical trials are needed, modeling tools provide new means of predicting 
the behavior of physiological signals. The behavior of a biological system can be 
simulated or formulated to a certain degree by models that approximate certain 
anatomical and physiological features, and models have been utilized in a number of 
biomedical applications. In electrocardiology, one of the earliest ECG models was the 
homogeneous thorax model used by Frank, the founder of the current vector ECG 
system (Frank 1954; Frank 1956). Later models have been especially valuable in 
applications where in vivo measurements are not always possible, such as in 
developing implantable devices. Thus, models have been used, e.g., for implantable 
defibrillator electrode comparison (Gale 1994), and for evaluation and optimization of 
defibrillation fields (Mohammed 1993; Panescu 1995).  
 
One important aspect of ECG is understanding what area of the model a certain lead 
measures. This can, for example, be achieved by studying the measurement sensitivity 
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distribution using the lead field. The formulation of lead field theory was originally 
introduced by Richard McFee and Franklin D. Johnston (McFee 1953; McFee 1954
a
; 
McFee 1954
b
), and it is further described in the Methods chapter. To mention a few 
applications, the lead field theory has been utilized in developing so-called aimed 
leads to detect local myocardial activation (Hyttinen 1994), for developing impedance 
cardiography (Kauppinen 1999; Kauppinen 2000), and for designing implantable ECG 
monitors (Väisänen 2006; Väisänen 2006). Apart from ECG, the lead field method has 
been used in analyzing the spatial resolution or sensitivity distributions of EEG 
(Väisänen 2008; Wendel 2010). In addition, we have used the lead field method to 
model the measuring sensitivity of facial EMG leads (Puurtinen 2005
b
). 
 
3.3 Body surface potential map data 
Body surface potential mapping (BSPM) is a technique used to capture high-resolution 
recordings of the heart’s activities by measuring the ECG signal from several 
electrodes on the subject’s chest (Figure 2). Compared to the traditional 12-lead 
system, BSPM provides higher spatial accuracy and amount of information for use in 
different applications (Nadeau 1995; Kornreich 1997). Hence, BSPMs contain 
diagnostic information not present in conventional lead systems and offer extensive 
material for analyzing different lead configurations. Kornreich et al. have utilized 
BSPM material to, e.g., identify the best ECG leads for diagnosing acute myocardial 
ischemia or LVH (Kornreich 1988; Kornreich 1989; Kornreich 1998). Regarding 
wearable systems, Finlay et al. investigated the issues of electrode placement in smart 
clothing (Finlay 2008). They analyzed a BSPM set of 192 unipolar leads, and based on 
their experiments, recommended using anterior and precordial areas.  
 
Regarding bipolar leads, BSPM has been utilized for determining the optimal region 
for a small implantable monitor (Burke 2003; Song 2004; Arzbaecher 2006), and it 
was found that closely spaced bipolar precordial leads can be used for automatic 
detection of acute ischemia, ventricular tachycardia (VT), or ventricular fibrillation 
(VF). Regarding surface ECG, Tomašić et al. recently introduced a multivariate linear 
regression–based synthesis of 12-lead ECG from three closely spaced bipolar leads 
(Tomašić 2010). In a further publication by Trobec et al., the researchers concluded 
that just three bipolar leads suffice for reliable synthesis of the 12-lead ECG (Trobec 
2011). 
 
Nevertheless, the problem of identifying the most appropriate site for a small wireless 
bipolar one-lead ECG device remains unsolved. This information would be useful for 
new emerging wireless, wearable, and handheld surface ECG devices. High-resolution 
BSPM recordings offer a valuable tool for testing multiple bipolar leads. 
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Figure 2. The 120 body surface potential map (BSPM) electrode locations in the Dalhousie 
lead system (Hoekema 1999). The black squares illustrate the location of the chest electrodes 
of the standard 12-lead system leads V1-V6. RA: right arm, LA: left arm, LF: left foot. [I] 
 
3.4 Left ventricular hypertrophy 
Left ventricular hypertrophy (LVH) is associated with the risk of cardiovascular 
events, including ischemic heart disease, vascular disease, and sudden death (Casale 
1986; Levy 1990; Koren 1991; Schillaci 2000). The importance of diagnosing LVH 
has increased in recent years with the recognition that hypertrophy can be reversed and 
the adverse clinical outcomes delayed with therapy (Mathew 2001; Okin 2003). LVH 
can be diagnosed with ECG, and the commonly used LVH-ECG criteria are based on 
12-lead system electrode locations and QRS voltages. Many voltage criteria have been 
introduced over the years, most notably by Sokolow and Lyon (Sokolow&Lyon 1949), 
who introduced the criterion based on the sum of SV1 (S amplitude in lead V1) and RV5 
or RV6 (R amplitude in lead V5 or V6) in 1949. Other criteria include the sum of SV3 
and RaVL, referred to as the Cornell voltage (Casale 1985), and the point score of 
Romhilt and Estes (Romhilt 1968). More recently, increasingly complex criteria have 
been developed, such as the computation of QRS area, composite use of several 
criteria, and incorporating multiple electrocardiographic and nonelectrocardiographic 
factors (Schillaci 1994; Norman 1995; Okin 1995; Okin 1996; Rautaharju 1996). 
Thus, the LVH-ECG criteria have evolved over the years, and the recent AHA 
Recommendations for the Standardization and Interpretation of the Electrocardiogram 
comprises recommendations for the standardization of LVH interpretation (Hancock 
2009).  
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LVH diagnostics has also evolved through BSPM data. Kornreich et al. identified the 
best unipolar leads for diagnosing LVH by statistical analysis of BSPMs (Kornreich 
1988; Kornreich 1989). They used time-normalized P, PR, QRS, and ST-T waveforms 
and the duration of these waveforms. The best five results were obtained from BSPM 
unipolar leads 24 and 38 at the lower precordium, leads 73 and 80 on the left side, and 
lead 113 on the back (see Figure 2 for electrode locations). Further, Oikarinen et al. 
assessed the capability of BSPM unipolar leads’ QRS area in LVH diagnosis 
(Oikarinen 2004). As best locations, they identified BSPM unipolar leads 9 and 10 on 
the lower right precordium, leads 7 and 13 on the upper right precordium, and lead 78 
on the left lower flank area (see Figure 2 for electrode locations). In addition, 
Malmqvist et al. studied the influence of using modified limb electrodes (limb leads 
placed on the abdomen instead of the extremities) on various LVH criteria (Malmqvist 
2000). They concluded that ECGs registered with modified limb electrode positions 
can be used to detect LVH with traditional ECG criteria, but changes in the limb leads 
are considerable and influence the sensitivities. 
 
The above-mentioned studies concentrate on unipolar leads or modified limb 
electrodes in the diagnosis of LVH. To our knowledge, the performance of bipolar 
leads with a short IED in LVH diagnosis has not been previously reported. Thus, one 
of the aims of this thesis (publication [III]) was to study the performance of a closely 
spaced bipolar lead in differentiating LVH subjects from normal subjects. 
 
3.5 Exercise test and coronary artery disease 
The exercise test is a diagnostic tool for evaluating the cardiovascular responses to 
physical exercise in a controlled clinical environment. The most common methods of 
exercise testing are the bicycle ergometer and the treadmill (Fletcher 1995; Froelicher 
2000). During the test, progressive workloads are used and patients’ ECG, blood 
pressure, respiration, and symptoms are monitored. 
In exercise ECG, the commonly used electrode placement is the Mason-Likar 
modification of the 12-lead system (Figure 3). In Mason-Likar, the conventional limb 
electrodes are placed at the base of the limbs instead of the extremities. Figure 3 also 
illustrates two additional leads, V4R and CM5, which can be used in exercise ECG. 
V4R is a unipolar lead with the WCT as the reference, and CM5 is a bipolar lead 
recorded between the manubrium (electrode M in Figure 2) and the location of the 
chest electrode of standard lead V5. 
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Figure 3. Mason-Likar modification of the standard 12-lead system electrode placement for 
exercise test and additional electrodes V4R and M for leads V4R and CM5. Modified from 
(Malmivuo 1995).  
 
Controlled exercise testing is an important diagnostic tool because it can bring out 
symptoms and characteristic changes on the ECG that become apparent only during 
physical exercise. Thus, the exercise test is generally used in the diagnosis of coronary 
artery disease. CAD is one of the main cardiovascular diseases, and is caused by 
atherosclerosis, which gradually reduces the blood flow capacity of the coronary 
arteries. Reduced blood flow may lead to ischemia of the heart muscle, and the first 
symptoms, such as chest pain, often occur during physical stress. The procedure for 
diagnosing CAD usually starts from detected symptoms, and the patient can be further 
examined with the exercise test.  
 
One of the main goals of the exercise test is to reveal clinically significant and 
symptomatic stenosis in coronary arteries. In the case of positive indications, coronary 
angiography can be conducted for further localization and measurement of the degree 
of the stenosis. The coronary arteries may also be examined by using computed 
tomography (CT) or single-photon emission computed tomography (SPECT). Still, the 
exercise test is an important diagnostic modality for the evaluation and diagnosis of 
cardiac conditions because it is noninvasive and has an independent prognostic value. 
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It gives information on whether the patient has symptoms during exercise, and on 
which workload or heart rate the symptoms are induced. 
 
All in all, the exercise test elicits changes in HR, blood pressure, respiration, and 
perceived level of exercise that provide information on patients’ cardiovascular and 
respiratory performance. In addition to these changes, exercise induces alterations in 
the ECG waveform. Normal changes include shortening of the PR, QRS, and QT 
intervals, an increase in the P-wave magnitude, and small changes in Q-waves 
(MacFarlane 1989; Simoons 1989; Jain 1995; Froelicher 2000). The most prominent 
abnormal change in ECG during exercise is ST-segment deviation, which is associated 
with exercise-induced ischemia in patients with significant coronary obstruction (Stern 
2002). The amount (mm or mV) of ST-segment deviation is generally measured 60 or 
80 ms after the J-point (the junction between the QRS and the ST-segment), and 
usually a positive test criterion of 1.0 mm (mV) ST-depression is used to indicate 
ischemia. 
 
One disadvantage of exercise testing is that it has limited sensitivity and specificity. A 
meta-analysis of 147 studies reported that exercise-induced ST-segment alterations 
identified coronary artery disease with a mean sensitivity of 68±16% and a mean 
specificity of 77±17% (Gianrossi 1989). The use of right precordial leads along with 
the standard six precordial leads has been reported to greatly improve the sensitivity of 
exercise testing for the diagnosis of CAD (Michaelides 1999). In addition, other 
studies that used recordings from the V4R lead during exercise testing have reported a 
small improvement in the detection of right CAD (Braat 1985; Chouhan 1989). 
However, other studies suggest that the application of right precordial leads does not 
improve the accuracy of the exercise ECG, even though it may contribute to the 
detection of ischemia perfused by the right coronary artery (Wierzbowska 2002; 
Ueshima 2004). Thus, there are controversial results as to whether additional leads 
improve the performance of exercise ECG. It has been reported that the exercise ECG 
leads have dissimilar diagnostic properties in the detection of CAD (Viik 2000), so it 
would be interesting to study the additional value of leads V4R and CM5 further. The 
benefit of lead CM5 is that it can be utilized in wireless applications, as it does not use 
the WCT as reference. In the Finnish Cardiovascular Study (FINCAVAS), leads V4R 
and CM5 are included in the exercise ECG protocol in addition to the standard 12-lead 
system (Nieminen 2006). Thus, it offers a valuable database for studying the 
performance of these additional leads in the detection of CAD.
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4. MATERIALS AND METHODS 
This thesis adopts three different approaches to test new bipolar ECG lead 
configurations: modeling, clinical BSPM data, and exercise ECG data. Section 4.1 
presents the modeling methods in the analysis of the measurement sensitivity of ECG 
leads, Section 4.2 presents the clinical BSPM database that was utilized to optimize 
bipolar electrode locations for normal subjects and for subjects with LVH, and Section 
4.3 presents the exercise ECG data that was utilized for evaluating additional ECG 
leads in CAD detection. Finally, Section 4.4 presents the statistical methods applied. 
 
4.1 Modeling of the measurement sensitivity of ECG 
4.1.1 Thorax models 
The models used in publication [I] were three-dimensional (3D) finite difference 
method (FDM) thorax models. FDM models are usually constructed from biomedical 
images, such as those obtained by magnetic resonance (MR) or CT. The modeled 
domain is subdivided or discretized into a grid of rectangular voxels, each with a 
resistivity defined by the corresponding tissue. The corners of a voxel form nodes and 
the conducting volume between adjacent nodes is replaced by an equivalent resistor. In 
this resistor network, most bioelectric field problems can be formulated in terms of 
either the Poisson or the Laplace equation, and an iterative method is used to 
approximate the solution at each node.  
 
In this thesis, two realistic but passive FDM models were used (the activation of the 
heart was not modeled), specifically a 3D model based on the visible human man 
(VHM) project and a 3D model based on MR images presenting the anatomy during 
diastole (Puurtinen 1999; Puurtinen 2001; Takano 2002). We hereafter refer to these 
models as Model 1 and Model 2, respectively. The anatomy of Model 1 was based on 
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a particularly accurate source of anatomical data, the U.S. National Library of 
Medicine’s (NLM’s) VHM data (NLM ; Ackerman 1991; Spitzer 1996; Spitzer 1997) 
and extracted from a full thorax model by Kauppinen and associates (Kauppinen 
1998). This model represented segmented transverse slice images of a male cadaver 
thorax, and included all visible details and 36 tissue types.  
 
The anatomy of Model 2 was derived from a set of MR images provided by Professor 
Robert Patterson, University of Minnesota. The image data comprised 70 transverse 
slices presenting the anatomy during diastole. Altogether, this model included 26 
distinct tissue types, including, e.g., intracavitary blood, the pericardium, major 
vessels, lungs, subcutaneous muscles and fat, bone, and some internal organs (liver, 
spleen). The main inhomogeneities included in the models and their resistivity values 
are listed in Table 1 (Puurtinen 1999; Hyttinen 2000; Takano 2002). Models 1 and 2 
are illustrated in Figure 4 with the appearance of the heart. For the current study, the 
resolution of both models was adapted so as to provide a more accurate presentation of 
the anatomy in the left anterior thoracic area, where the cardiac sources are located. In 
this area, the element size was 3.3 mm x 3.3 mm x 4 mm in Model 1 and 3 mm x 3 
mm x 5 mm in Model 2, increasing toward the back of the thorax and to the right side. 
The resolution of the back and right sides of the thorax models were made coarser in 
order to enable calculations on the otherwise heavy 3D models. Model 1 included a 
total of 258,442 nodes and Model 2 a total of 253,468 nodes. 
 
Table 1. The main inhomogeneities included in the models and their resistivity values. 
 
Inhomogeneity Resistivity (Ω cm) 
Bone 2,000 
Lungs 1,325 
Subcutaneous fat 2,000 
Skeletal muscle 400 
Liver 600 
Stomach 400 
Heart fat 2,000 
Heart muscle 450 
Blood masses* 150 
Other tissues and organs 460 
*Including intracardiac blood masses, great 
arteries, and veins 
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Figure 4. The realistic 3D thorax models: (a) model based on the visible human man project; 
(b) model based on magnetic resonance images presenting the anatomy during diastole [I]. 
 
4.1.2 Modeling calculations 
In study the properties of ECG electrode configurations, the lead field theory provides 
a means of estimating the measurement sensitivity and thus the signal strength. The 
model calculations in publication [I] were based on the lead field and reciprocity 
theorems. The relationship between the measured signal VLE in the lead and the cardiac 
current sources iJ  in the volume conductor can be formulated as follows: 
                  
1 i
LELEV J J dv

                                                (1), 
where LEJ  is the lead field and  is the conductivity of the volume conductor 
(Malmivuo 1995). Thus, if the lead field and the properties of the volume conductor 
are known, the strength of the measured signal VLE can be estimated. The problem is 
simplified by assuming a case of uniform source distribution; thus, the lead sensitivity 
can be expressed as an average of the lead vectors JLE. The reciprocity theorem states 
that the location of the source (equivalent dipoles in the heart muscle) and the detector 
(electrodes) can be interchanged without any change in the signal amplitudes 
(Malmivuo 1995). We therefore applied a reciprocal current to the measuring 
electrodes located on the model, and calculated the resulting lead field in the heart 
muscle. To obtain the average measuring sensitivity for the whole source (heart 
muscle) area, we calculated the average magnitude of the resultant lead field vectors in 
the heart muscle. This represented the leads, i.e., the electrodes’ sensitivity to 
measuring the electric source of the heart. Then, to evaluate whether the modeling 
results represented the actual clinical data, we compared the modeled measuring 
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sensitivity with the signal strength obtained from the clinical BSPM data. A total of 
117 unipolar and 42 bipolar leads were studied. The methods are further described in 
publication [I]. 
 
For the modeling calculation, we utilized bioelectric field software that was originally 
developed by Walker at the University of Tasmania (Walker 1985; Walker 1987). The 
software has been further developed by Hyttinen and Kauppinen et al. (Hyttinen 1994; 
Kauppinen 1999), and the version used in publication [I] of this thesis was developed 
by Takano (Takano 2002). 
 
4.2 Body surface potential map data 
4.2.1 BSPM material for normal and LVH subjects 
In this thesis, a BSPM database was utilized for three purposes: (a) validating the 
modeling results [I], (b) defining optimal locations for a small bipolar ECG device [II], 
and (c) defining optimal locations for a small bipolar ECG device to differentiate 
subjects with LVH from normal subjects [III]. The BSPM database was kindly 
provided by Professor Friedrich Kornreich, Vrije Universiteit Brussel, Belgium. These 
BSPM data consisted of 120-lead ECGs acquired from 236 normal subjects and 305 
subjects with LVH. The presence of LVH was diagnosed from ECG-independent 
information, specifically from echocardiography, cardiac catheterization with coronary 
angiography and ventriculography, radionuclide angiography, chest radiographs, or 
cardiac surgery. The LVH population was further subdivided into 116 pure left-sided 
valvular disease or sustained hypertension (150/90 mmHg or higher) and 189 complex 
LVH patients with various cardiac conditions frequently associated with LVH 
(Kornreich 1989; Kornreich 1993).  
 
The electrode system comprised three unipolar limb leads (RA: right arm, LA: left 
arm; LF: left foot) and 117 body surface unipolar leads. The 117 body surface 
electrode positions were defined with a grid of 9 rows and 18 columns. This electrode 
system is referred to by Hoekema as the Dalhousie lead system (Hoekema 1999). The 
electrode locations are illustrated above in Figure 2. These BSPM ECG data contained 
preprocessed and parameterized unipolar signals recorded with WCT as reference. The 
data sample from each subject comprised ensemble averages of ECG voltages at 52 
time points set in a time-normalized P-to-T complex waveform (Kornreich 1989). 
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4.2.2 Electrode locations 
The unipolar leads studied in this thesis corresponded to those of the original BSPM 
data. The bipolar electrode locations were chosen in the left precordial area, as the 
ECG signal arises there. The precordial area and especially the locations close to the 
chest electrodes of the standard leads V1-V6 were expected to give the best signal 
strength, as well as information on interindividual variability. As the BSPM data 
included only unipolar leads, the bipolar leads were formed by subtracting the signals 
of selected unipolar leads from one another. 
 
In publication [I], the BSPM data were utilized to validate the results of the modeling 
study. A total of 117 unipolar and 42 bipolar leads (14 horizontal, 28 vertical) were 
studied (Figure 5 (a)). The 117 unipolar locations were those in the original BSPM 
data, and the bipolar electrode locations were chosen so that they would be close to the 
chest electrodes of the standard leads V1-V6. As illustrated in Figure 5 (a), the bipolar 
leads represented different IEDs; in this way, we could also evaluate the effect of IED 
on signal strength.  
 
In publication [II], the aim was to optimize the location and direction of a small 
plaster-like ECG sensor; thus, only bipolar leads with short IEDs were analyzed. The 
distance was approximately 5 cm vertically, 6 cm horizontally, and 6 cm diagonally, 
depending on the person’s size. The rationale for this electrode spacing was that the 
original BSPM data directly supported this spacing, and that it represents a possible 
size for a wearable or implantable ECG device. A total of 42 vertical, 35 horizontal, 
and 36 diagonal bipolar leads were analyzed to find the lead locations that would 
maximize the ECG signal strength within normal subjects (Figure 5 (b)). 
 
In publication [III], the aim was to test the performance of small ECG sensors in 
detecting LVH. We studied similar bipolar lead configurations to those in publication 
[II], and added one diagonal lead direction. An additional lead direction was included 
because LVH is known to shift the QRS axis (Wagner 2007), and we considered that 
new electrode directions could give additional information. The formed bipolar leads 
on the anterior thorax included 36 vertical, 30 horizontal, 36 diagonal sloping 
downwards left (dL), and 30 diagonal sloping downwards right (dR) leads (Figure 6). 
These bipolar leads were analyzed to find those that best differentiated LVH subjects 
from normal subjects. The electrode numbering was adjusted in publication [III] for 
practical reasons; electrode 1 in publication [III] corresponded to electrode 19 in the 
original BSPM data. 
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In all three publications [I-III], the bipolar signals were obtained by subtracting the 
unipolar BSPM signals of selected electrode pairs from each other using a Matlab 
script. In publication [I], the IED varied, as illustrated in Figure 5 (a). In publications 
[II] and [III], the IEDs of the bipolar leads were 5–6 cm.  
 
 
 
                                         (a)                                                                   (b) 
 
Figure 5. Location of bipolar leads analyzed in a) publication [I], b) publication [II]. Analyzed 
electrodes are numbered and colored in grey. Black squares denote the location of the chest 
electrodes of leads V1-V6 in standard 12-lead ECG [I, II]. 
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Figure 6. Location of bipolar leads analyzed in publication [III]. Leads oriented (a) vertically, 
(b) horizontally, (c) diagonally sloping downwards left (dL), and (d) diagonally sloping 
downwards right (dR). Black circles denote the location of the chest electrodes of standard 
12-lead ECG precordial leads [III]. 
 
4.2.3 Signal analysis 
In this thesis, signal analysis was utilized to detect and calculate the average P-wave 
and QRS complex amplitudes from the 120-lead BSPM ECG signals recorded from 
different persons. These amplitudes were chosen to represent the lead’s signal 
strength. 
 
The ECG signal analysis for publications [I-III] was conducted with Matlab. To 
validate the modeling method in publication [I], we compared the modeled measuring 
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sensitivity with the signal strength obtained from corresponding electrodes in BSPM. 
The average QRS amplitude was chosen to represent the ECG signal strength in 
BSPM data. We calculated the peak-to-peak value (the sum of the absolute values of 
negative and positive amplitudes) of the QRS complex to give the full amplitude 
during ventricular activation, and calculated the average QRS amplitude within all 236 
normal patients. 
 
To optimize the location of a small bipolar lead within normal subjects in publication 
[II], both QRS complex and P-wave amplitudes were derived from the 120 bipolar 
lead signals. The QRS amplitude was calculated as in publication [I]. Similarly, the P-
wave amplitude was calculated—with the baseline adjusted to the TP (the plateau 
phase between T wave and P-wave) segment—to give the amplitude during atrial 
activation. QRS and P amplitudes were defined for each subject and the average and 
standard deviation were determined. The P-wave was targeted, as it is usually one of 
the smallest of the diagnosed parameters in the ECG, and thus is the first to disappear 
under noise. For reference, we compared the signal amplitudes obtained from bipolar 
leads to noise levels of 15 µV and 60 µV; these values represent a fairly low and a 
rather high noise level in normal ECG measurements (Fernandez 2000; Huigen 2002). 
Noise values were taken from the literature, as noise could not be analyzed from 
readily parameterized and preprocessed BSPM data. 
 
In publication [III], the BSPM ECG signals were utilized to evaluate the performance 
of new small bipolar leads in LVH diagnosis. We studied whether small bipolar leads 
are able to discriminate subjects with LVH from normal subjects based on QRS 
amplitude. Thus, the QRS amplitude was defined for each subject and each lead. For 
reference, the analysis was also conducted for standard leads V1, V2, and V4, which 
were available in the BSPM database. The subjects in the ECG database were divided 
into two groups: normal (n=236) and LVH (n=116). The performance of the bipolar 
leads in differentiating LVH subjects from normal subjects was further assessed with 
receiver operating characteristic (ROC) analysis, which is presented in Section 4.4.  
4.3 Exercise ECG data for CAD 
4.3.1 FINCAVAS database 
In publication [IV], the approach was slightly different from the other publications. 
While publications [I]-[III] analyzed the performance of new small bipolar leads for 
wireless applications utilizing BSPM data, publication [IV] analyzed the value of leads 
V4R and CM5 in CAD detection utilizing exercise ECG data. The reasoning for this 
was that CM5 is also a bipolar lead located on the chest (see Figure 3), and it could be 
used in wireless and portable applications. CM5 could be especially useful in wearable 
t-shirt ECG systems, such as that developed by the Finnish CorusFit Oy and Tampere 
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University of Technology. Their solution includes wearable ECG monitoring during 
group training, and their rehabilitation programs and methods can be applied among 
people at risk for or already diagnosed with CAD (CorusFit ; Vehkaoja 2008). One of 
the leads measured in CorusFit WiEKG and SensorWear is similar to lead CM5. Thus, 
it is interesting to evaluate the performance of this lead using an exercise ECG 
database. 
 
The exercise ECG database used in publication [IV] was a previously documented 
FINCAVAS database (Nieminen 2006). The purpose of FINCAVAS is to construct a 
risk profile of individuals at high risk of cardiovascular diseases, events, and death. 
The FINCAVAS has an extensive set of data on patient history, genetic variation, 
cardiovascular parameters, ECG markers, and follow-up data on clinical events, 
hospitalizations, and deaths. Between October 2001 and December 2008, all patients 
scheduled for a standardized clinical exercise test at Tampere University Hospital, 
Tampere, Finland and willing to participate in the study were recruited. About 20% of 
the patients had also undergone coronary angiography within 6 months of exercise 
testing. The study protocol in FINCAVAS was approved by the Ethical Committee of 
the Hospital District of Pirkanmaa, Finland, and all patients gave informed consent 
prior to the interview and measurements, as stipulated in the Declaration of Helsinki. 
 
The published FINCAVAS database comprises information on 2,212 patients 
examined between October 2001 and December 2004 (Nieminen 2006). For 
publication [IV], patients with an exercise test shorter than 4 min, left or right bundle 
branch block, LVH, type 1 diabetes, and those taking digitalis medications were 
excluded. In addition, patients who underwent coronary artery bypass surgery between 
the exercise test and angiography and patients with a recent (< 8 weeks) myocardial 
infarction were also excluded.   
 
For publication [IV], the patients were further divided into the following three 
subgroups based on angiography and clinical history. 
 
Angiographically proven CAD (CAD). This group consisted of patients who had > 
50% luminal diameter narrowing in at least one major epicardial coronary artery or 
side branch. The CAD group comprised 255 patients, of which 201 were men and 54 
women. 
 
No CAD by angiography (NoCAD). This group consisted of patients who had no 
evidence of CAD either in the major coronary arteries or in the side branches. The 
NoCAD group comprised 126 patients, of which 62 were men and 64 women. 
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Low likelihood of CAD (LLC). This group consisted of patients who did not undergo 
coronary angiography but had no clinical signs of cardiac diseases. To be included in 
this subgroup, the patients needed to have no history of cardiac disease and no cardiac 
medication (short- or long-acting nitrates,  blockers, digitalis, diuretics, calcium [Ca] 
channel blockers, angiotensin converting enzyme [ACE] inhibitors, or angiotensin 2 
antagonists). In addition, the patients did not have angina pectoris during exercise, and 
the probability of CAD was considered to be low according to the supervising 
physician. The LLC group comprised 198 patients, of which 117 were men and 81 
women. 
 
4.3.2 Exercise test protocol 
Prior to the exercise stress test, the subject lay down in a supine position for 10 min, 
and the resting ECG was digitally recorded. The exercise test was performed using a 
bicycle ergometer, and the ECG lead system was the Mason-Likar (Mason 1966) 
modification of the standard 12-lead system and an additional two electrodes for 
recording leads V4R and CM5 (Nieminen 2006). During the test, HR was 
continuously registered with ECG; the systolic (SAP) and diastolic (DAP) arterial 
pressures were measured with a brachial cuff every 2 min. 
 
The continuous ECG was recorded at 500 Hz with the CardioSoft exercise ECG 
system (Version 4.14, GE Healthcare, Freiburg, Germany) and analyzed by Modified 
CASE software (GE Healthcare, Freiburg, Germany). All ECG parameters recorded 
during the exercise were determined at 14 points in time: before exercise, seven times 
during the exercise (start, 2 min, 4 min, 6 min, 8 min, 10 min, and maximal load), and 
six times during recovery after the exercise at the end of each minute up to 6 min. 
 
4.3.3 ST-segment analysis 
We used ST-segment depression as a parameter to evaluate whether the application of 
leads V4R and CM5 enhanced the diagnostic performance of the exercise ECG in the 
detection of CAD. The variable used in the ROC analysis of publication [IV] was ST-
segment depression at peak exercise. ST-segment depression was determined from the 
12-lead system and from the additional leads V4R and CM5. Leads V1 and aVL were 
excluded from the study. Leads aVR and V4R were inverted because of the rightward 
direction of the leads. When studying lead sets, the maximum value over the studied 
leads was used as the classifier for the variable. ST-segment amplitudes were 
measured to the nearest 10 µV at a point 60 ms after the J-point. The traditional 
positive test criterion for ST-segment depression was used (< -0.10 mV ST-segment 
value, i.e., > 1.0 mm ST depression). Angiography was employed as a reference 
method; this is considered to be the ultimate diagnostic method for CAD because it 
directly measures the degree of stenosis in the coronary vessels. 
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4.4 Statistical analysis 
The statistical analysis was conducted with Matlab for publications [I] and [II], and 
with SPSS 16.0 for publications [III] and [IV]. 
4.4.1 Traditional statistical methods 
To assess the relationship between the modeled measuring sensitivity and the signal 
strength obtained from actual ECG data in publication [I], we conducted a linear 
correlation analysis with a least-squares fit to calculate the Pearson’s linear correlation 
coefficient. The correlation coefficient indicates to what extent the datasets are linearly 
associated (Draper 1998). 
 
In publication [II], one aim was to define which electrode location provides a strong 
and reliable signal independent from the subject. For this, the average and standard 
deviation (SD) of P-wave and QRS amplitudes were calculated. Standard deviation 
shows the extent to which the data samples differ from the average value (Dunn 1974). 
One SD away from the mean accounts for around 68% of the values, and two SDs 
away account for around 95%, assuming that the data is normally distributed. Thus, we 
used the SD to describe how reliable the recording site was within different 
individuals. 
  
In publications [III] and [IV], sensitivity and specificity were used as parameters of the 
diagnostic properties of the leads. Sensitivity is the proportion of true positives that are 
correctly identified by the test (e.g., the percentage of sick people who are identified as 
having the condition). Specificity is the proportion of true negatives that are correctly 
identified by the test (e.g., the percentage of healthy people who are identified as not 
having the condition) (Altman 1994). 
 
For a general description of the patient group characteristics in publication [IV], the 
variables were examined by statistical tests. The categorical variables were examined 
by Pearson’s chi square test, and quantitative variables were examined by independent 
samples t-test. The independent samples t-test compares the mean scores of two 
groups on a given normally distributed variable. It can be used to draw conclusions 
about the means of two populations, and to tell whether or not they are similar. It tests 
the hypothesis that the difference between the means of two samples is equal to 0 (the 
null hypothesis). One of the results given by the t-test is the two tailed probability p. 
When this so-called p-value is less than the conventional 0.05 or 0.01 (5% or 1% 
chance of rejecting the null hypothesis when it is true), the null hypothesis is rejected 
and the conclusion is that the two means do indeed differ significantly (Uhari 2001). 
The lower the p-value, the more statistically significant the result will be. 
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4.4.2 Receiver operating characteristic analysis 
In publications [III] and [IV], the overall diagnostic performance of the studied leads 
was evaluated using receiver operating characteristic analysis. An ROC curve is a 
graphical plot of sensitivity vs. (1-specificity) (Figure 7). The perfect classification 
method would yield a point in the upper left corner of the plot area. This would 
represent 100% sensitivity (no false negatives) and specificity (no false positives). 
Again, the diagonal line x = y represents the strategy of random classification. 
Accordingly, values 1 and 0.5 for the area under the ROC curve represent perfect 
classification and random classification; respectively. The area under the ROC curve 
(hereafter referred to as the ROC area) represents the probability that a random pair of 
patients with and without the condition will be correctly diagnosed (Hanley 1982). The 
ROC curve includes all values of the selected variable and was plotted using different 
variables, specifically QRS amplitude and ST depression, in publications [III] and 
[IV], respectively. 
 
 
 
Figure 7. Characteristics of the ROC curve. The diagonal dashed line represents the strategy 
of random classification (ROC area = 0.5) and the full line represents an example ROC curve 
with an area of 0.71. 
 
In [III], ROC analysis was used to evaluate the performance of new short-distance 
bipolar leads in differentiating LVH subjects from normal subjects. The diagnostic 
variable used in the ROC analysis was the QRS amplitude, i.e., the maximum peak-to-
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peak value of the signal during ventricular activation. For further analysis of the signal 
level in the bipolar leads that provided the highest ROC areas, the average and SD of 
the QRS amplitudes were calculated for both normal subjects and subjects with LVH.  
 
In [IV], the ROC analysis was used to assess the value of additional leads CM5 and 
V4R in exercise ECG and CAD diagnostics. In this case, the diagnostic variable in the 
ROC analysis was ST-segment depression at peak exercise. First, ROC analysis was 
conducted for individual leads CM5, V4R, and V5. Lead V5 was included as a 
reference because it has been shown to be capable of detecting most ischemic 
responses when a positive criterion of 1.0 mm ST depression is used (Tucker 1976; 
Fox 1984; Miller 1987; London 1988). Second, to evaluate whether the additional lead 
CM5 or V4R improve the diagnostic performance, ROC analysis was conducted for 
the following lead sets: standard leads (i.e., the 12-lead system with the exclusion of 
V1 and aVL); standard leads + CM5; and standard leads + V4R.  
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5. RESULTS 
This chapter presents the main results of publications [I]-[IV]. The discussion related 
to each section will take place in Chapter 6 in the respective sections. 
5.1 Modeling the sensitivity of ECG leads 
In [I], we evaluated whether the ECG signal strength can be estimated by modeling the 
measuring sensitivity with two realistic 3D thorax models (Figure 4). A total of 117 
unipolar and 42 bipolar leads were analyzed. 
 
Unipolar leads 
The results for 117 unipolar leads are illustrated in Figure 8. The signal strength 
obtained from clinical BSPM data and the measuring sensitivity obtained with Model 
2 from 117 BSPM unipolar leads (see Figure 4 for electrode numbering) are illustrated 
in Figure 8 (a). The signal strength was plotted as a function of the electrode 
location/number. It can be observed that the modeled measuring sensitivities 
corresponded to the actual BSPM signal strength. However, within unipolar leads 
located on the heart area, such as electrodes 45 to 60, modeling gave higher values 
than the clinical data. In contrast, among the unipolar leads locating on the left anterior 
side, such as electrodes 68 to 76, the clinical data gave higher values than the 
modeling.  
 
The correlation between signal strength obtained from clinical BSPM data (on the y-
axis) and measuring sensitivity obtained from Model 2 (on the x-axis) for the 117 
unipolar BSPM torso leads is illustrated in Figure 8 (b). The correlation coefficient 
between these two datasets was r = 0.86 (n = 117, p < 0.05). 
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                   (a)              (b) 
 
Figure 8. (a) The measuring sensitivity (left y-axis, arbitrary units) obtained from a realistic 
thorax model (Model 2) and the signal strength (right y-axis) obtained from clinical BSPM 
ECG data for 117 BSPM unipolar leads. See Figure 4 for electrode numbering. (b) The 
correlation between the singnal strength from clinical BSPM data (y-axis) and the measuring 
sensitivity obtained from Model 2 (x-axis, arbitrary units), and the linear regression line. The 
data points correspond to the same 117 unipolar leads as in (a) [I]. 
 
 
Bipolar leads 
The results for the 42 bipolar leads (i.e. electrode pairs) are illustrated in Figure 9 (a) 
for 14 horizontal and (b) for 28 vertical leads. The three curves in each plot represent 
the signal strength obtained from clinical BSPM data, the measuring sensitivity 
obtained from Model 1, and the measuring sensitivity obtained from Model 2.  
 
In Figure 9 (a), the uppermost, middle, and undermost curves illustrate the values for 
horizontal bipolar leads on levels 1, 2, and 3, respectively (see Figure 4 (a)). At each 
level, the leads’ IED increases from left to right, being 6 cm in leads 36–43, 37–33, 
and 38–45. It can be seen that the absolute measuring sensitivity values from both 
models were different from the clinical data, but the pattern was similar. Thus, the 
modeled measuring sensitivity corresponded to the relative change in actual signal 
strength between different leads. 
 
In Figure 9 (b), the uppermost, middle, and undermost curves illustrate the results for 
vertical bipolar leads between levels 1 and 2, 2 and 3, and 1 and 3, respectively. The 
uppermost curve in Figure 9 indicates that in bipolar leads between levels 1 and 2, 
Model 1 corresponded quite well with the results from clinical data. In leads between 
levels 1 and 3, clinical data gave higher values when moving towards the heart area (to 
the right).  
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From the linear regression analysis for all 42 bipolar leads in Figure 9, the correlation 
was r = 0.62 between Model 1 and the clinical data, and r = 0.71 between Model 2 and 
the clinical data (n = 42, p < 0.05 for both). 
 
 
   
 
                  (a)           (b) 
 
Figure 9. The signal strength obtained from clinical BSPM data and the measuring 
sensitivities obtained from Model 1 and Model 2 for (a) horizontal and (b) vertical bipolar 
leads. The leads were formed from electrode pairs on different levels. See Figure 4 for levels 
and electrode numbering. In (a), the interelectrode distance (IED) increases when going to the 
right. In (b), the IED is 5 cm between levels 1 and 2 and levels 1 and 3, and 10 cm between 
levels 1 and 3. The modeling data are in arbitrary units, so the unit of y-axis is mV [I]. 
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5.2 The signal quality provided by new bipolar ECG leads 
To evaluate whether the signal provided by small bipolar leads is strong enough for 
clinical utilization, we analyzed 120 bipolar leads in terms of QRS and P-wave 
amplitude in [II]. The amplitudes were calculated as an average from the BSPM ECG 
of 236 normal subjects. Figure 10 illustrates the average QRS and P-wave amplitudes 
for 120 bipolar leads (i.e., electrode pairs). The uppermost, middle, and bottom-most 
figures represent diagonal, vertical, and horizontal leads, respectively. Each graph 
includes leads from different rows on the chest denoted as, e.g., R 1-2 for diagonal and 
vertical leads and R 1 for horizontal leads. See Figure 5 (b) for row and electrode 
numbering.   
 
The leads providing the highest amplitudes are indicated with filled squares. 
Generally, it was observed that the diagonal leads provided the best performance. This 
is logical, since these leads lie in the direction of the heart’s main electrical activity. 
The highest QRS amplitudes (~2250 µV) were obtained from diagonal leads (electrode 
pairs) 37–45 and 44–52. The highest P-wave amplitudes (~100 µV) were obtained 
from diagonal leads 20–29 and 21–30. 
 
If we assumed a reference noise level of 60 µV, the QRS amplitude was higher than 
the noise in all studied bipolar leads. However, with this noise level, the P-wave 
amplitude was too small in all horizontal and most diagonal and vertical leads. Only 8 
leads between rows 2–3 and 6 leads between rows 3-4 provided P-wave amplitudes 
higher than 60 µV. However, when comparing the results with 15 µV, which 
represents a low noise situation, all studied leads provided a detectable P-wave and 
QRS-complex. 
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Figure 10. QRS (left column) and P-wave amplitudes (right column) obtained from 120 
bipolar leads (electrode pairs) on the BSPM. The uppermost, middle, and bottom-most figures 
represent diagonal, vertical, and horizontal leads, respectively. The rows in which electrodes 
are located are indicated as R 1-2, R 2-3, etc. Each row includes six squares for diagonal, 
seven squares for vertical, and five squares for horizontal leads. On the x-axis, only the first 
lead is denoted for each row. When moving to the right on the graphical illustration, the lead 
is moving towards the left side of the subject’s chest. The filled squares denote the leads 
providing the highest signal amplitudes. See Figure 4 for row and electrode numbering [II]. 
 
  
5.3 Optimal location for new bipolar ECG leads for healthy 
subjects 
From the results in Figure 10, we can select the bipolar leads providing the highest 
QRS and P-wave amplitudes. These diagonal, vertical, and horizontal leads are further 
illustrated in Figure 11. The leads that maximize the QRS amplitude are depicted in 
black, and the leads that maximize the P-wave are depicted in gray. 
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It can be observed from Figure 11 that for all lead orientations, the leads located near 
standard precordial leads V2-V4 provided the highest QRS amplitudes. 
Correspondingly, the best area for P-wave detection was among or right above the 
chest electrodes of standard leads V1 and V2. Among the leads depicted in Figure 11, 
the highest QRS amplitudes were obtained from diagonal leads (electrode pairs) 37–45 
and 44–52. Accordingly, the highest P-wave amplitudes were obtained from diagonal 
leads 20–29 and 21–30. See the electrode numbering in Figure 4 (b). 
 
 
 
Figure 11. The (a) diagonal, (b) vertical, and (c) horizontal bipolar leads providing the highest 
QRS (black) and P-wave (grey) amplitudes. Black squares denote the location of the chest 
electrodes of standard 12-lead system leads V1-V6 [II]. 
5.4 The value of new bipolar ECG leads in diagnosing LVH and 
CAD 
The previous chapters presented the performance of new bipolar leads by analyzing 
cases with normal ECG. This information is valuable when designing new monitoring 
devices for healthy subjects. This chapter introduces a more clinical point of view, 
specifically an analysis of the performance of new bipolar leads in detecting patients 
with LVH or CAD. 
 
Detecting LVH patients 
In [III], we evaluated whether closely separated (6 cm) bipolar leads can differentiate 
subjects with LVH from subjects with normal ECG. The material contained 120-lead 
BSPM ECGs from 236 normal and 116 LVH subjects. A total of 36 vertical, 30 
horizontal, and 66 diagonal bipolar leads were studied (Figure 6). The average QRS 
amplitudes were calculated, and the leads’ overall diagnostic performance was 
assessed by ROC analysis. 
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We found that the new bipolar leads are efficient in discriminating subjects with LVH 
from normal subjects. The leads providing good overall performance (ROC ≥ 0.70 or 
ROC ≤ 0.30) are illustrated in Figure 12. The classification rule for ROC areas 0.50 or 
greater was that LVH subjects have higher amplitudes, and the rule for ROC areas 
0.50 or smaller was that healthy subjects have higher amplitudes. Multiple diagonal 
dL, diagonal dR, and vertical leads on the lower anterior thorax provided good (18, 24, 
and 30, ROC > 0.70) or very good (vertical 24, ROC > 0.80) overall performance. The 
performance of the lower horizontal leads (6, 24, and 30) was also good (ROC > 0.70). 
In addition, vertical leads 10 and 16, located higher on the thorax, provided a good 
overall diagnostic capacity, but with the opposite rule for the amplitude (ROC ≤ 0.30). 
This means that higher on the chest (e.g., lead 16), the average QRS amplitudes were 
lower in the LVH group than within normal subjects, whereas in the lower anterior 
area (e.g., lead 24), the opposite was the case. These QRS amplitude relationships are 
also illustrated in Figure 12 as light and dark grey areas.  
 
 
 
 
Figure 12. Best bipolar leads for detecting left ventricular hypertrophy (LVH). Arrows denote 
the location and orientation of each lead. These leads provided a good overall diagnostic 
performance in differentiating LVH subjects from normal subjects (ROC area ≥ 0.70). 
Modified from [III]. 
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To compare the performance of the new bipolar leads with that of an existing LVH 
criterion, the ROC curves for the average QRS amplitude in two bipolar vertical leads 
(16 and 24) and for the traditional Sokolow-Lyon criterion are illustrated in Figure 13. 
In addition, the performance of QRS amplitude in bipolar lead locations 16 and 24 and 
of the Sokolow-Lyon criterion is further illustrated in Table 2, in which ROC areas, 
sensitivity values at 90% and 95% specificities, and cutoff values are listed. Locations 
16 and 24 were selected, as they provided the highest overall performance of the 
studied bipolar leads. According to the ROC curves in Figure 13, the overall 
performances of bipolar vertical leads 16 and 24 are comparable to that of the 
Sokolow-Lyon criterion. Furthermore, it can be seen from Table 2 that the vertical and 
diagonal bipolar leads at location 24 provided similar or higher sensitivities in relation 
to the traditional Sokolow-Lyon criterion at both 90% and 95% specificities when 
differentiating LVH subjects from normal subjects. These leads had similar ROC areas 
(0.77–0.81) and cutoff points (1,030–1,060 µV), which means that with a bipolar lead 
located in this area, the direction is not that critical. 
 
 
 
Figure 13. ROC curves to differentiate subjects with LVH from normal subjects. The QRS 
amplitude from bipolar vertical leads 16 and 24 and the Sokolow-Lyon criterion were used as 
variables [III]. 
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Table 2. ROC area, sensitivity, and cutoff point at 90% and 95% specificities for QRS 
amplitude in bipolar lead locations 16 and 24 and for the Sokolow-Lyon criterion, comparing 
LVH subjects to normal subjects [III]. 
Lead ROC area  
Sensitivity at 
90% specificity 
Cutoff point (µV)  
at 90% specificity 
Sensitivity at  
95% specificity 
Cutoff point (µV)  
at 95% specificity 
Bipolar 16      
   Vertical 0.27 35% <816 14% <558 
   Horizontal 0.54 22% >2901 11% >3250 
   Diagonal dL 0.32 27% <1066 12% <772 
   Diagonal dR 0.30 28% <756 16% <487 
Bipolar 24      
   Vertical 0.81 59% >765 34% >1054 
   Horizontal 0.72 42% >1356 33% >1654 
   Diagonal dL 0.77 49% >860 37% >1060 
   Diagonal dR 0.79 54% >856 41% >1030 
Sokolow-Lyon  
(SV1+RV5/V6) 
0.73 42% >4255 35% >4881 
dL = diagonal downward left, dR = diagonal downward right. See Figure 6 for lead locations.  
 
Detecting CAD patients 
In [IV], our aim was to evaluate the diagnostic performance of leads CM5 and V4R in 
the detection of CAD. The material comprised 579 patients referred for a bicycle 
exercise ECG test in the Finnish Cardiovascular Study, and the patients were divided 
into three groups: angiographically proven CAD (CAD, n = 255), no CAD by 
angiography (NoCAD, n = 126), and low likelihood of CAD (LLC, n = 198). The 
diagnostic accuracy of leads CM5 and V4R was assessed with ROC analysis, and the 
parameter used in the analysis was maximum ST-depression at peak exercise. The 
ROC analysis was conducted for two group comparisons: CAD vs. LLC and CAD vs. 
NoCAD. The analysis was conducted both for individual leads and for lead sets, where 
V4R and CM5 were added to the standard lead system.  
 
Individual leads 
The ROC areas and the sensitivity and specificity values at -0.10 mV ST segment 
values for individual leads V5, CM5, and V4R are listed in Table 3, and the 
corresponding ROC curves are illustrated in Figure 14 (a). In Figure 14, the squares 
indicate -0.10 mV ST segment values, and the open and closed circles indicate -0.15 
and -0.05 mV ST values, respectively. In both comparisons (CAD vs. LLC and CAD 
vs. NoCAD), the ROC areas obtained from lead CM5 (0.72 and 0.57) were 
comparable to those of lead V5 (0.72 and 0.58). At -0.10 mV ST-segment value, lead 
CM5 provided a higher sensitivity but lower specificity than lead V5. In addition, the 
ROC area, sensitivity, and specificity of lead CM5 were similar to those of the 
standard 12-lead system. The ROC areas obtained from lead V4R were smaller (0.61 
and 0.53) than those of CM5 and V5, and the sensitivity of lead V4R was low (7%). 
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Among the individual leads, lead V5 gave the highest sensitivity (47%) at -0.10 mV 
ST-segment value. 
 
Lead sets 
The ROC areas and the sensitivity and specificity values at -0.10 mV ST segment 
values for the lead sets are listed in Table 3, and the corresponding ROC curves are 
illustrated in Figure 14 (b). It can be observed from this figure that adding lead CM5 to 
the standard leads did not change the ROC area but increased the sensitivity and 
decreased the specificity in both group comparisons. Adding lead V4R did not notably 
change the sensitivity or specificity, but decreased the ROC area. 
 
 
 
                                              (a)                                                                              (b) 
 
Figure 14. The ROC curves and areas under the curve for ST-depression at peak exercise 
recorded (a) from individual leads V5, CM5, and V4R, and (b) from the following lead sets: 
Standard, Standard + CM5, and Standard + V4R. Standard: Standard leads with the exclusion 
of V1 and aVL. Solid lines indicate comparison between coronary artery disease (CAD) and 
low likelihood of CAD (LLC) groups, and dashed lines indicate comparison between 
angiographically proven CAD and no-CAD (NoCAD) groups. The closed circles, squares, 
and open circles indicate ST-segment values of -0.05 mV, -0.10 mV, and -0.15 mV, 
respectively [IV]. 
 
 
 
 
 
  
 
Results 
 
43 
Table 3. Diagnostic performance of individual leads V5, CM5, and V4R, and the lead sets. 
Modified from [IV]. 
 Individual leads       Lead sets 
 V5 CM5 V4R Standard
a Standard  
+ CM5 
Standard 
+ V4R 
CAD vs. LLC      
ROC area 0.72 0.72 0.61 0.71 0.71 0.69 
Sensitivity at -0.10 mV  
ST-segment value (%) 
38 47 7 48 54 49 
Specificity at -0.10 mV  
ST-segment value (%) 
88 80 98 81 73 80 
       
CAD vs. NoCAD       
ROC area 0.58 0.57 0.53 0.55 0.55 0.53 
Sensitivity at -0.10 mV  
ST-segment value (%) 
38 47 7 49 54 50 
Specificity at -0.10 mV  
ST-segment value (%) 
71 60 91 57 52 55 
CAD = coronary artery disease, LLC = low likelihood of CAD  
a
Standard leads with the exclusion of V1 and aVL. 
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6. DISCUSSION 
This chapter discusses the main results, findings, and limitations of our research. First, 
we address the results obtained from the modeling study. Second, we discuss whether 
short-distance bipolar leads can provide an ECG signal that is adequate for clinical 
utilization. Third, we recommend how those bipolar leads should be located in order to 
obtain the best ECG signal strength within healthy subjects. Fourth, we assess the 
value of new bipolar leads in diagnosing LVH and CAD. Finally, we discuss the value 
of new bipolar leads in future healthcare. 
6.1 Modeling the sensitivity of new ECG leads 
The purpose of this thesis was to study the properties of new bipolar ECG leads for 
wireless and wearable applications. One possible method for evaluating the 
performance of new electrode configurations is modeling the bioelectric fields with a 
computer model. However, it was unclear how well the modeled measuring sensitivity 
corresponds to the actual signal strength. To study the value of the modeling method, 
we compared the results from realistic 3D thorax models with clinical 120-lead BSPM 
data. Our results show that the measuring sensitivity modeled with realistic thorax 
models and with lead field method corresponds to the actual ECG signal strength. 
When modeling the unipolar leads, the correlation coefficient between Model 2 and 
BSPM data was r = 0.86 (n = 117, p < 0.05), which can be considered good 
correlation. In the case of bipolar electrode pairs, the correlation was lower, at r = 0.62 
between Model 1 and BSPM data, and r = 0.71 between Model 2 and BSPM data. 
These results indicate that the unipolar leads are less sensitive to individual variation 
than the bipolar leads. This is probably because short bipolar leads are more localized 
and thus more sensitive to changes in the position, orientation, and electrical properties 
of the heart and other underlying tissues. In general, the modeling method was able to 
predict the relative changes in signal strength. However, in the left precordial area, the 
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clinical data gave higher values than modeling. This was due to the fact that the 
direction of the heart’s electric axis, which normally slopes downwards left, increased 
the signal in the electrodes at the cardiac apex area. This increase was not seen in the 
models, as they are passive. This is one limitation of our models: They do not include 
the heart’s electrical activity, but only take into account the tissue resistivities and 
geometries. Another limitation concerns the sensitivity distribution. Our calculations 
assume a uniform source over the heart muscle, but in the beating heart, the electric 
source is dynamic and constantly changing. On the other hand, a passive model has the 
benefit of providing more generalized results, as it is not confined to a certain 
condition. With increasing computing power, however, it may also be possible to 
include and more specifically define the cardiac activity into the models, thereby 
enhancing their accuracy in more specific cases.  
 
One limitation of this study is that the models represented only the thorax anatomy of 
two individuals. Yet, the models were different from each other. Model 1 was made 
from cryosections, and represented a large person, whereas Model 2 was made from 
live MR images and represented a smaller person of Asian origin. From these two, 
Model 2 seemed to better predict the actual signal strength. This may have been 
related to the postmortem data of the VHM project or because the anatomy of the 
VHM model is far from being representative of the general population. However, 
along with developing image processing methods and computing power, it is possible 
to create individualized models based on MR or CT images. In this way, the properties 
of new recording leads could be tested individually for each person. Another future 
possibility is to create models representing a certain condition, such as LVH. Further 
modeling could include designing leads for a specific cardiac area, or monitoring the 
area of known arterial stenosis or the arrhythmogenic zone. 
 
It should be noted that modeling does not give absolute signal strength values, but it 
does provide information on the relative changes in signal strength. Thus, modeling 
can be utilized when comparing different electrode locations. Another major benefit of 
modeling in general is that it provides a fast way of testing new electrode 
configurations. This is useful when designing wearable or wireless systems and 
choosing the appropriate electrode locations. We may conclude that the measuring 
sensitivity data computed from the realistic 3D thorax models will be useful when 
developing new electrode montages and measurement systems. 
 
Regarding the BSPM data that were utilized in this thesis to validate the modeling 
results, the major limitation was that we did not have access to detailed patient 
characteristics such as age, gender, obesity, ethnicity, medication, and so on. However, 
as this study has a technical scope and focuses on evaluating the performance and 
comparing different ECG leads, we believe that the results are still useful, as the 
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number of subjects was high. Most importantly, the BSPM that we used offered an 
extensive ECG database for testing different electrode configurations and for 
evaluating the performance of new bipolar leads in both healthy and LVH subjects. 
6.2 The signal quality provided by new bipolar ECG leads 
Bipolar ECG leads have been utilized in a variety of wireless, wearable, and 
implantable ECG devices during the last decade. However, it is important to evaluate 
the signal quality provided by closely-spaced electrodes. The BSPM data on 236 
normal subjects offers extensive data for testing different electrode configurations. By 
analyzing the average QRS and P-wave amplitudes on 120 bipolar leads on the 
anterior thorax, we found that most of the bipolar ECG leads with a short IED 
(approximately 6 cm) provided a detectable ECG signal in healthy subjects. The 
highest QRS (~2250 µV) and P-wave (~100 µV) amplitudes were obtained from 
diagonal leads located close to leads V2-V3 and leads V1-V2; respectively. It is 
logical that the diagonal leads record the strongest signal, as the main cardiac activity 
is usually directed diagonally, and the strongest signal is projected to the lead parallel 
to the activation front. In contrast, the lowest signal strength was obtained from 
horizontal bipolar leads. Further, all leads located on the highest or lowest rows on the 
chest provided a poor signal strength. 
 
The results were also compared to reference noise levels of 15 µV and 60 µV. The 
QRS amplitude was higher than 60 µV in all bipolar leads, which means that for 
applications requiring only the detection of HR, all studied bipolar leads are adequate. 
The P-wave amplitudes were higher than 60 µV in only 14 of the studied leads. These 
leads were located above the precordial electrodes of standard leads V1-V2. 
Nevertheless, in comparison with a reference noise level of 15 µV, all studied bipolar 
leads provided a detectable P-wave. A recent thesis (Väisänen 2008) reported that the 
measurement noise can be reduced to a level of 1–4 µVrms. These measurements were 
conducted in a normal unshielded laboratory, and thus these levels should be 
achievable in most measurement environments. Nevertheless, the noise created by 
movement and muscle activity is usually higher, especially when measuring a mobile 
person. Thus, the required signal level depends on the application, the measurement 
environment, and the movement artifacts. 
6.3 Optimal location for new bipolar ECG leads for healthy 
subjects 
As mentioned in the previous chapter, the bipolar leads directed diagonally provided 
the highest QRS and P-wave amplitudes. In contrast, the lowest amplitudes were 
obtained from horizontal leads. The results also showed that the best location for QRS 
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complex is around the chest electrodes of the standard precordial leads V2, V3, and 
V4, and that the optimal location for P-wave detection is above the chest electrodes of 
leads V1 and V2. This result is logical, since QRS complex arises from ventricular and 
P-wave from atrial activation. Similarly, based on their measurements, Fensli et al. 
(Fensli 2004) reported that the optimal position for their plaster-like ECG sensor (IED 
3 cm) is in the 4
th
 and 5
th
 intercostal spaces at the apex of the heart. Our results 
regarding the detection of QRS complex support this finding, as the chest electrodes of 
leads V3 and V4 lie in the same area. 
 
It should be noted that in our study, the amplitudes were calculated as an average from 
236 subjects, and the recorded signal strength varied among different individuals. 
However, the findings give an indication of the optimal location for a small ECG 
device for different purposes. If the aim is to detect the HR or to concentrate on the 
QRS complex, then the optimal location is likely to be that providing the highest QRS 
amplitude. In the case of classifying cardiac arrhythmias, such as atrial fibrillation 
(AF), the location providing highest P-wave amplitude is probably the best choice. 
This information will be useful when designing the electrode locations for a small 
wireless, wearable, or implantable ECG device. 
 
Another interesting aspect regarding wearable systems would be identifying the best 
combination of 2 to 3 bipolar leads or using classification methods other than pure 
amplitude. Recently, Tomašić et al. introduced a multivariate linear regression based 
synthesis of 12-lead ECG from three bipolar leads (Tomašić 2010). They reported that 
their study was motivated by our results of publication [I], which showed that a bipolar 
lead with 6 cm interelectrode distance provides an acceptable S/N ratio. In a further 
publication by Trobec et al., the researchers analyzed sets of two, three, and four 
differential leads, and concluded that just three bipolar leads suffice for reliable 
synthesis of the 12-lead ECG (Trobec 2011). The best locations for healthy subjects 
corresponded to three bipolar leads—(41, 43), (43, 59), and (59, 61) in Figure 4(b). 
Their results support the assumption that closely spaced bipolar leads provide an 
adequate representation of the heart’s electrical activity, and that new precordial 
bipolar leads have potential in future healthcare. 
 
6.4 The value of new bipolar ECG leads in diagnosing LVH and 
CAD 
So far, we have found that a correctly positioned small bipolar ECG lead is able to 
provide sufficient signal amplitude to detect the main parameters of ECG. After this, 
we wanted to test the value of small bipolar leads in diagnosing cardiovascular 
conditions. LVH and CAD were chosen because they are among the main 
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cardiovascular diseases and our data provided information on patients with these 
conditions. The results are discussed below. 
 
Left ventricular hypertrophy (LVH) 
When analyzing the BSPM of 236 normal and 116 LVH subjects, it was observed that 
new closely spaced bipolar leads are able to detect subjects with LVH. Furthermore, 
the performance of the best bipolar leads was similar to that of the traditional 
Sokolow-Lyon criterion. Another major finding was that the bipolar leads with the 
best overall diagnostic performance were located in two areas, one near the precordial 
electrodes of standard leads V1 to V3, and the other on lower anterior thorax (Figure 
12). It was interesting to see that the classification rule was different in these two 
areas. In the bipolar leads located lower on the thorax, the QRS amplitudes were 
higher in the LVH group than within normal subjects. In contrast, in the bipolar leads 
located near the precordial electrodes of V1-V3, the QRS amplitude was lower in the 
LVH group than within normal subjects. Generally, the opposite is the case, as LVH is 
associated with high QRS voltages in the precordial unipolar leads V1, V2, V5, and 
V6. 
 
The reason for the lower amplitudes in the new precordial bipolar leads could be that 
the thickening of the left ventricular wall enhances all body surface potentials in the 
precordial area, thereby decreasing the potential difference detected by two closely 
lying bipolar lead electrodes. Another possible reason is that the shifting of the QRS 
axis related to LVH shortens the projection detected by the bipolar leads, hence 
inducing smaller amplitudes. It is known that LVH causes the QRS frontal axis to shift 
slightly leftward and the QRS transversal axis to shift markedly posteriorly (Wagner 
2007). Furthermore, a recent modeling study suggested that it is a combination of 
anatomical and electric remodeling that creates the QRS complex changes seen in 
LVH patients (Bacharova 2009).  
 
Regarding the complex changes involved in LVH, we conducted a further study on 
short bipolar leads by including a so-called complex LVH group in the analysis 
(Väisänen 2010). The study population consisted of 236 healthy subjects, 116 pure 
LVH patients with either pure left-sided valvular disease or sustained hypertension 
(150/90 mmHg or higher) and 189 complex LVH patients with various cardiac 
conditions frequently associated with LVH (Kornreich 1993). We found that the best 
bipolar leads provided a better overall performance (normal vs. complex, ROC=0.85; 
normal vs. pure, ROC=0.81) than the traditional Sokolow-Lyon method (normal vs. 
complex, ROC=0.67; normal vs. pure, ROC=0.73). The QRS amplitude criteria were 
different, and the ROC areas were higher when differentiating complex LVH patients 
from normal patients than when differentiating pure LVH patients from normal 
patients. These results support our previous finding that precordial bipolar leads with a 
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short IED can discriminate subjects with LVH from normal subjects. Our results also 
indicate that the ECG changes in LVH vary depending on the type of LVH (pure vs. 
complex), which makes the diagnosis more challenging. There are certain limitations 
to our study on LVH. In the dataset, the male and female patients were not separated, 
so we cannot state how gender affects the performance of bipolar leads. It should also 
be noted that although large voltage differences were noticed between normal subjects 
and subjects with LVH, there is also large interindividual variability.  
 
In general, the results of this thesis show that new small precordial bipolar leads could 
provide advanced tools for LVH diagnostic. These new leads cannot replace the 
standard 12-lead system, but they can give additional value, especially in wearable or 
implantable long-term measurements. In the future, it would be interesting to analyze 
the performance of bipolar leads further by identifying the best combination of 2 or 3 
bipolar leads. Utilizing multiple leads would have the advantage of allowing changes 
to be sensed in different directions. Another interesting area would be to apply other 
classification methods than pure amplitude, such as time-voltage QRS area.  
 
Regarding the use of short bipolar leads in other cardiac conditions, Arzbaecher et al. 
(Arzbaecher 2006) reported that ECGs recorded by a small subcutaneous monitor 
(interelectrode distance 4 cm) are of sufficient quality and amplitude to allow accurate 
detection of VT/VF. Further, the performance of closely spaced bipolar leads in 
ischemia detection has been reported by Song et al. (Song 2004). These studies 
support our finding on the applicability of small, closely spaced bipolar leads in ECG 
analysis. 
 
Coronary artery disease (CAD) 
Among CAD patients, the maximal ST depression most commonly occurred in leads 
V5 and V6, regardless of disease location and severity (Mason 1967; Fuchs 1982). It 
has been reported by Viik et al. (Viik 1997; Viik 1998) that in addition to leads V5 and 
V6, leads I and -aVR also exhibit high performance when differentiating between 
patients with CAD and patients with a low likelihood of the disease. This indicates that 
the importance of leads I and -aVR has been undervalued. The benefit of leads V5 and 
V6 is that the signal amplitude is high in that area. In leads -aVR and I, the amplitude 
is lower, so that the effective use of these leads requires a 50% smaller partition value 
than that used in the lateral precordial leads (e.g., -0.05 mV ST depression). It is worth 
noting that leads –aVR and CM5 have a quite similar lead vector direction in the 
frontal plane. Regarding lead CM5, based on 100 male subjects, Chaitman et al. 
(Chaitman 1978) have reported that incorporating leads CM5, CC5, and CL with 
standard leads improves the sensitivity and efficiency of the maximal treadmill 
exercise test. Correspondingly, our study with both male and female subjects showed 
that when adding lead CM5 with standard leads, the specificity decreases, but the ROC 
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area remains the same and the sensitivity increases. These results indicate that bipolar 
lead CM5 could be useful in applications where high sensitivity is emphasized. 
Regarding lead V4R, Michaelides et al. have stated that the use of right precordial 
unipolar leads along with the standard six precordial leads greatly improves the 
sensitivity of exercise testing for the diagnosis of CAD (Michaelides 1999). However, 
our results do not support this finding, as in our study, adding lead V4R to the standard 
lead system did not notably change the sensitivity or specificity, but decreased the 
ROC area. 
 
Bowles et al. (Bowles 1985) compared the results obtained from 18 unipolar 
precordial leads and those from bipolar leads CM5 and CC5. The data included 21 
patients with severe angina and luminal narrowing of at least 70% in one or more 
major coronary arteries. In all cases the ST depression exceeded 1 mm in both CM5 
and CC5 at the peak of exercise. The magnitude of ST depression was greater in the 
bipolar leads in 75% of cases and in the remaining 25% the greatest peak ST 
depression occurred in a single unipolar lead. Again, Guiteras et al. (Guiteras 1982) 
studied the diagnostic accuracy of 14-lead exercise electrocardiography in 112 women 
who had no history of myocardial infarction and underwent coronary angiography. 
The sensitivity of ST-segment displacement of 0.1 mV or more in any of studied ECG 
leads was 79% for coronary artery stenosis of at least 70%, and the specificity was 
66%. Results were similar using bipolar ECG leads CC5 and CM5 or 11 standard ECG 
leads (excluding aVR). In our results, including both males and females, we also found 
that the performance of lead CM5 is similar to both that of standard lead V5 and that 
of 10 standard leads (excluding V1 and aVR). When analyzing single leads, CM5 gave 
a lower specificity but a higher sensitivity and a similar ROC area than lead V5. This 
means that CM5 detects more CAD patients than V5. Furthermore, the sensitivity, 
specificity, and ROC area of CM5 were similar to that of 10 standard leads. Based on 
this, it could even be concluded that a single lead CM5 is enough for CAD detection. 
In the future, lead CM5 may be especially valuable in wireless or wearable 
applications, as the lead’s location enables it to be integrated into a t-shirt and the 
measurement field encompasses the precordial area. One commercial solution 
benefiting from wearable ECG measurement is the Finnish CorusCardio concept by 
CorusFit Oy (CorusFit ; Vehkaoja 2008). This company’s preventive and 
rehabilitation programs and methods can be applied among people at risk for or 
already diagnosed with CAD. One of the bipolar leads integrated into the CorusFit 
WiEKG and SensorWear is similar to lead CM5. Our results further support the use of 
this lead in wearable or wireless cardiac solutions. 
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6.5 The value of new bipolar leads in future healthcare 
This thesis assessed the value of new bipolar leads in different applications, 
specifically general ECG recording within healthy subjects and detecting ECG 
changes in the cardiovascular diseases LVH and CAD. The specific conclusions of this 
thesis are introduced in the following chapter. To sum up, our main findings were that 
a closely spaced (5–6 cm) bipolar lead provides a strong ECG signal within healthy 
subjects, and is also able to detect LVH patients when the lead is correctly positioned 
on the thorax. We also found that the performance of bipolar lead CM5 is similar to 
that of standard lead V5 and that of 10 standard leads (excluding V1 and aVR) in 
detecting CAD patients with exercise ECG. These results show that the new bipolar 
leads work surprisingly well, both when monitoring the normal ECG and when 
detecting cardiac conditions. 
 
These new bipolar leads can be utilized in the wireless, portable, or implantable 
devices that have been emerging during the past decade. Wireless solutions in 
healthcare can improve the patient care, reduce costs, and enable individuals to take 
more active approach to their health. Wireless remote monitoring could, for example, 
add value to athletes’ training, increase the safety of elderly people living at home, and 
enable monitoring of patients suffering from paroxysmal atrial fibrillation or angina 
pectoris. With small, unobtrusive ECG devices, it would be possible to detect events 
that are currently missed, as the episode might be over when the individual arrives at 
the healthcare center. In the future, it might even be possible for patients to interface 
with their doctors through, e.g., a smartphone. 
 
The additional value of small bipolar leads is that they enable the development of 
lightweight measurement devices. Along with the improvements in electronics design, 
it is possible to generate devices—including electrodes, measurement electronics, and 
wireless signal transfer—in a small, plaster-like device. The small size and absence of 
lead wires improve patient comfort and reduce motion artifacts. Further, the possibility 
of integrating monitoring devices into clothing enables new ways of monitoring 
cardiac activity. These novel, wearable devices permit the acquisition of ECG signals 
for a variety of applications ranging from emergency care to long-term monitoring at 
home. Further, with increasing computing power, more sophisticated patient 
monitoring ECG devices can be developed. One important application where bipolar 
electrodes are already utilized is implantable monitoring, such as the cardiac event 
monitors by Medtronic (Medtronic) and St. Jude Medical (StJudeMedical). 
 
Another benefit of the bipolar leads is the modifiable measurement field. The standard 
12-lead system precordial leads are referred to WCT and detect electrical changes in a 
large volume. The measurement field of closely spaced bipolar leads lies within a 
smaller volume, and thus can be targeted to detect changes in a certain area. This could 
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allow us to develop leads tailored to a certain condition, for a certain individual, or to 
detect changes in atrium or ventricle. In other words, as the 12-lead system is a widely 
utilized standard measurement of cardiac function, small bipolar leads can be designed 
to give more specific information. Further, short bipolar leads can also be derived from 
the standard 12-lead system electrodes. Including these short bipolar leads in the 
analysis could give additional value to the diagnostics. 
 
One limitation of small, portable ECG systems is the limited number of leads. 
Moreover, the short lead vectors and close proximity to the heart result in ECG 
amplitudes and morphologies that differ from more familiar recording techniques. 
These changes in the measured ECG affect the outcome of the diagnosis. Thus, the 
application of new bipolar ECG leads requires new criteria to be set for diagnostics. 
Hence, further research on the signals and parameters provided by novel bipolar leads 
is needed in order to apply them in clinical use.  
 
What kind of research is needed for these systems to become widespread? First, the 
devices need to be user-friendly, lightweight, portable, and provide data in real time, 
before they will gain public acceptance. In particular, the user interfaces should be 
convenient and easy to use. It would also be beneficial if the new wearable systems 
could be integrated with the existing measurement platforms. To distinguish between 
different users, the signals should be identified, and a high level of security is needed 
when dealing with healthcare data. Further, real-time signal analysis would be 
beneficial in order to, e.g., detect cardiac events. In addition, the healthcare systems 
and databases need to be developed so that the service behind these devices is also 
available, e.g., a doctor interpreting the signals and acting accordingly.  
 
Regarding wearable textiles and mobile measurement in general, one of the main 
challenges involves reducing movement artifacts and ensuring stable contact between 
the skin and the recording electrode. One of the limitations of this thesis is that most of 
our ECG data were collected in a static position. The mobile aspect was involved only 
in the exercise ECG data. However, the purpose of this thesis was to concentrate on 
the hardware aspect and electrode placing. A natural extension of this work would be 
to collect mobile ECG data in different circumstances, and to develop adaptive signal 
processing algorithms that compensate for the physical movements of the subject. 
Finally, although this thesis gives new information on the performance of small 
bipolar ECG leads, further research among different populations and in different 
circumstances is required before such ECG systems become widely accepted among 
clinicians. 
 
The 12-lead ECG still remains the main diagnostic tool for heart disease, as no other 
technique has gained such widespread and sustained acceptance. Yet, new lead 
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systems are being developed and investigated. Novel, closely spaced bipolar leads can 
give new information to electrocardiology because they detect different types of 
changes in the ECG signal than standard leads. The challenge is that the standard 12-
lead system is so widely accepted that the new possible lead configurations are still far 
from everyday use. However, the results of this thesis are promising and indicate that 
in the future, novel wearable or implantable monitors can be offered as new tools for 
ECG diagnostics. 
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7. CONCLUSIONS 
According to the specific aims of the study, the following conclusions were made: 
 
1. The results of lead field modeling analysis [I] demonstrated that the modeled 
measuring sensitivities correlated with the actual measured ECG data. Modeling 
provided information on the relative changes in the ECG signal strength when 
changing the electrode location and IED. Thus, lead field–based analysis of 
realistic, 3D thorax models provides an additional tool for the design of new ECG 
leads, e.g., for wireless or implantable solutions.  
 
2. All studied bipolar ECG leads with a short IED (approximately 6 cm) provided a 
detectable signal when compared to a low noise level of 15 µV and considering the 
P-wave as the smallest parameter [II]. With a higher noise level of 60 µV, only 
certain bipolar leads oriented diagonally or vertically provided detection of the P-
wave. However, the QRS complex was detectable in all studied leads. 
 
3. The optimal orientation for a bipolar lead with a short IED was diagonally on the 
chest [II]. The best locations regarding the QRS complex and P-waves were around 
the chest electrodes of the standard precordial leads V2, V3, and V4, and above the 
chest electrodes of leads V1 and V2, respectively. 
 
4. In clinical evaluation, it was found bipolar ECG leads with a short IED were able to 
discriminate between subjects with LVH and healthy subjects [III]. Moreover, 
vertical and diagonal bipolar leads on the lower anterior thorax provided similar 
overall diagnostic performance to the traditional Sokolow-Lyon method. 
Considering the additional bipolar lead CM5 in CAD diagnostics, we found that the 
performance of this lead is comparable to that of standard lead V5 [IV]. Further, by 
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adding lead CM5 to the standard 12-lead system, the sensitivity of the exercise test 
was increased. 
 
This study consisted of modeling the sensitivity, optimizing the location, and 
evaluating the clinical performance of new bipolar ECG leads. We may conclude that 
modeling can be useful, especially in cases where in vivo measurements are 
impossible, such as in the design of implantable applications. Based on actual ECG 
data, it was observed that when correctly positioned, the short IED bipolar leads 
provide an ECG where all the parameters are detectable. Moreover, in selected clinical 
applications—LVH and CAD—the performance of the new bipolar leads was 
surprisingly good, as it was comparable or even better than those of the methods 
commonly used today. These results indicate that when correctly positioned, short IED 
bipolar leads are useful and can even give additional value for clinical diagnostics. In 
general, this thesis gives new information on the performance and value of small 
bipolar ECG leads, and consequently facilitates and contributes to the development of 
new wireless and portable measurement devices for general use as well as for clinical 
diagnostics. 
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